Precigen (PGEN) Research & Development: 2012-2025
Historic Research & Development for Precigen (PGEN) over the last 14 years, with Sep 2025 value amounting to $12.4 million.
- Precigen's Research & Development rose 8.86% to $12.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.1 million, marking a year-over-year decrease of 15.11%. This contributed to the annual value of $53.1 million for FY2024, which is 9.17% up from last year.
- Precigen's Research & Development amounted to $12.4 million in Q3 2025, which was up 7.74% from $11.5 million recorded in Q2 2025.
- Precigen's Research & Development's 5-year high stood at $15.7 million during Q2 2024, with a 5-year trough of $10.5 million in Q1 2025.
- Its 3-year average for Research & Development is $12.4 million, with a median of $11.9 million in 2023.
- Its Research & Development has fluctuated over the past 5 years, first surged by 44.03% in 2021, then dropped by 26.80% in 2025.
- Over the past 5 years, Precigen's Research & Development (Quarterly) stood at $12.2 million in 2021, then dropped by 11.37% to $10.8 million in 2022, then increased by 20.39% to $13.0 million in 2023, then declined by 9.51% to $11.8 million in 2024, then climbed by 8.86% to $12.4 million in 2025.
- Its Research & Development was $12.4 million in Q3 2025, compared to $11.5 million in Q2 2025 and $10.5 million in Q1 2025.